Compare Abbott India with Fresenius Kabi Onco. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs FRESENIUS KABI ONCO. - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA FRESENIUS KABI ONCO. ABBOTT INDIA/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 55.8 22.1 252.3% View Chart
P/BV x 16.5 3.1 531.5% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 ABBOTT INDIA   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
FRESENIUS KABI ONCO.
Mar-13
ABBOTT INDIA/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs8,834176 5,019.4%   
Low Rs5,45879 6,952.2%   
Sales per share (Unadj.) Rs1,731.137.7 4,593.5%  
Earnings per share (Unadj.) Rs211.95.1 4,160.8%  
Cash flow per share (Unadj.) Rs219.96.7 3,270.5%  
Dividends per share (Unadj.) Rs65.000-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs945.242.5 2,221.7%  
Shares outstanding (eoy) m21.25158.23 13.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.13.4 122.2%   
Avg P/E ratio x33.725.0 135.0%  
P/CF ratio (eoy) x32.518.9 171.7%  
Price / Book Value ratio x7.63.0 252.8%  
Dividend payout %30.70-   
Avg Mkt Cap Rs m151,84820,135 754.2%   
No. of employees `0003.51.2 302.5%   
Total wages/salary Rs m4,356703 619.4%   
Avg. sales/employee Rs Th10,555.55,176.2 203.9%   
Avg. wages/employee Rs Th1,249.9610.4 204.8%   
Avg. net profit/employee Rs Th1,292.2699.6 184.7%   
INCOME DATA
Net Sales Rs m36,7865,963 616.9%  
Other income Rs m1,13318 6,293.9%   
Total revenues Rs m37,9195,981 634.0%   
Gross profit Rs m6,0471,430 422.9%  
Depreciation Rs m169258 65.6%   
Interest Rs m23-26 -86.5%   
Profit before tax Rs m6,9891,216 574.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m2,485342 726.2%   
Profit after tax Rs m4,503806 558.8%  
Gross profit margin %16.424.0 68.5%  
Effective tax rate %35.628.1 126.4%   
Net profit margin %12.213.5 90.6%  
BALANCE SHEET DATA
Current assets Rs m27,6105,102 541.2%   
Current liabilities Rs m8,5692,385 359.2%   
Net working cap to sales %51.845.6 113.6%  
Current ratio x3.22.1 150.7%  
Inventory Days Days60150 40.1%  
Debtors Days Days27113 24.2%  
Net fixed assets Rs m1,0575,148 20.5%   
Share capital Rs m213158 134.3%   
"Free" reserves Rs m19,8736,556 303.1%   
Net worth Rs m20,0866,732 298.4%   
Long term debt Rs m0952 0.0%   
Total assets Rs m29,40910,388 283.1%  
Interest coverage x311.6-45.8 -680.7%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.30.6 217.9%   
Return on assets %15.47.5 205.0%  
Return on equity %22.412.0 187.3%  
Return on capital %34.914.6 239.0%  
Exports to sales %074.5 0.0%   
Imports to sales %024.8 0.0%   
Exports (fob) Rs mNA4,441 0.0%   
Imports (cif) Rs mNA1,477 0.0%   
Fx inflow Rs m3695,298 7.0%   
Fx outflow Rs m4,9181,772 277.5%   
Net fx Rs m-4,5493,525 -129.0%   
CASH FLOW
From Operations Rs m4,9911,274 391.8%  
From Investments Rs m-2,570-1,204 213.4%  
From Financial Activity Rs m-1,428-196 728.2%  
Net Cashflow Rs m993-126 -786.5%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 81.0 92.6%  
Indian inst/Mut Fund % 7.9 0.3 2,633.3%  
FIIs % 0.1 9.6 1.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 9.1 187.9%  
Shareholders   18,270 42,599 42.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   DISHMAN PHARMA  ELDER PHARMA  ALEMBIC LTD  ALEMBIC PHARMA  WOCKHARDT  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Crashes 1,203 Points; IT and Banking Stocks Witness Selling(Closing)

Indian share markets extended losses in the first trading session of FY21, as the number of coronavirus cases in the country continued to rise.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020(The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock(Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

Lockdown! Now the Bailout...(The Honest Truth)

Mar 25, 2020

Ajit Dayal on what India should do to manage the coronavirus impact on the economy.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Apr 1, 2020 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS